M. Dewhurst et al., EFFECTS OF AMINOGUANIDINE AND N-G-NITRO-L-ARGININE METHYL-ESTER ON VASCULAR-RESPONSES OF AORTAE AND LUNGS FROM STREPTOZOTOCIN-DIABETIC RATS, Prostaglandins, leukotrienes and essential fatty acids, 56(4), 1997, pp. 317-324
Aminoguanidine (AG) treatment can prevent the development of some func
tional anomalies in experimentally diabetic rats, possibly via the pre
vention of a diabetes-induced vascular dysfunction. The acute effects
of AG on endothelium-dependent relaxation of aortae in the presence of
indomethacin and on presser responses and prostacyclin release in iso
lated perfused lungs, were therefore investigated using tissues from c
ontrol and streptozotocin-diabetic rats. Endothelium-dependent relaxat
ions of aortae were reduced by aminoguanidine (control 20%, and diabet
ic 25%). For lungs, angiotensin II-induced presser responses were unaf
fected by AG, whereas the nitric oxide synthase inhibitor L-NAME cause
d integrated presser responses to be increased in lungs from control a
nd diabetic rats (2.0 and 1.8 fold respectively). Individually, AG (1
mM) and L-NAME (10 mu M) did not affect total cumulative prostacyclin
release by control lungs, whereas significant increases for both were
observed for diabetic lungs. In summary, these studies firstly provide
evidence that AG can increase prostacyclin release from tissues in vi
tro, with little effect upon endothelium-dependent vasodilatation, and
secondly, that the regulation of vasodilator prostanoid release by th
e pulmonary circulation of the rat may be altered in experimental diab
etes.